We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+16.77%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+281.48%
AUM
$44.6B
AUM Growth
+$5.78B
(+15%)
Cap. Flow
+$1.14B
Cap. Flow
% of AUM
2.56%
Top 10 Holdings %
Top 10 Hldgs %
19.14%
Holding
4,226
New
302
Increased
2,051
Reduced
1,607
Closed
183
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$126M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$78.8M |
| 3 |
Invesco NASDAQ 100 ETF
QQQM
|
+$69M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$63.9M |
| 5 |
Putnam Focused Large Cap Value ETF
PVAL
|
+$51.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$73.5M |
| 2 |
Invesco Ultra Short Duration ETF
GSY
|
+$67.5M |
| 3 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$63.2M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$54.6M |
| 5 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$52.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.77% |
| 2 | Financials | 4.22% |
| 3 | Industrials | 3.52% |
| 4 | Consumer Discretionary | 3.02% |
| 5 | Communication Services | 2.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Carlyle Group
CG
$16.1B
| $788K | ﹤0.01% |
18,709
-6,771
| -27% | -$318K |
|
2527
Fluence Energy
FLNC
$1.58B
| $788K | ﹤0.01% |
+39,627
| New | +$737K |
|
2528
BondBloxx Bloomberg Ten Year Target Duration US Treasury ETF
XTEN
$1.04B
| $788K | ﹤0.01% |
17,296
-3,539
| -17% | -$161K |
|
2529
Preformed Line Products
PLPC
$1.39B
| $787K | ﹤0.01% |
1,917
-3,953
| -67% | -$1.39M |
|
2530
ActivePassive International Equity ETF
APIE
$1.12B
| $786K | ﹤0.01% |
20,287
-765
| -4% | -$28.9K |
|
2531
Fidelity International High Dividend ETF
FIDI
$360M
| $786K | ﹤0.01% |
28,707
+17,764
| +162% | +$498K |
|
|
STEL
2532
DELISTED
Stellar Bancorp
STEL
| $786K | ﹤0.01% |
20,000
-35
| -0.2% | -$1.32K |
|
2533
Atlantic Union Bankshares
AUB
$6.05B
| $785K | ﹤0.01% |
18,552
+3,245
| +21% | +$124K |
|
2534
LPL Financial
LPLA
$27B
| $783K | ﹤0.01% |
2,779
+68
| +3% | +$20.4K |
|
2535
West Pharmaceutical
WST
$23.7B
| $783K | ﹤0.01% |
2,180
-189
| -8% | -$57.8K |
|
2536
Gartner
IT
$11.1B
| $781K | ﹤0.01% |
6,028
+4,597
| +321% | +$692K |
|
2537
Xtrackers US National Critical Technologies ETF
CRTC
$130M
| $780K | ﹤0.01% |
20,006
-100
| -0.5% | -$3.81K |
|
2538
Piper Sandler
PIPR
$4.99B
| $780K | ﹤0.01% |
10,778
+408
| +4% | +$33.1K |
|
2539
Voya Financial
VOYA
$8.96B
| $778K | ﹤0.01% |
8,592
-282
| -3% | -$23K |
|
2540
Weatherford International
WFRD
$5.9B
| $778K | ﹤0.01% |
9,545
-78
| -0.8% | -$7.91K |
|
|
TOPT
2541
iShares Top 20 U.S. Stocks ETF
TOPT
$647M
| $778K | ﹤0.01% |
23,628
+15,564
| +193% | +$505K |
|
2542
iShares Genomics Immunology and Healthcare ETF
IDNA
$190M
| $777K | ﹤0.01% |
23,022
+12
| +0.1% | +$360 |
|
2543
Nutrien
NTR
$33.9B
| $777K | ﹤0.01% |
12,342
-668
| -5% | -$46.7K |
|
2544
Sabesp
SBS
$18.4B
| $776K | ﹤0.01% |
134,230
-5,610
| -4% | -$34K |
|
2545
Myers Industries
MYE
$1.24B
| $775K | ﹤0.01% |
21,950
+4,903
| +29% | +$115K |
|
|
VZLA
2546
Vizsla Silver
VZLA
$1.1B
| $775K | ﹤0.01% |
235,875
-8,153
| -3% | -$28.3K |
|
2547
AllianzIM U.S. Equity Buffer10 May ETF
MAYT
$231M
| $774K | ﹤0.01% |
19,835
+84
| +0.4% | +$3.23K |
|
2548
iShare MSCI Eurozone ETF
EZU
$9.38B
| $772K | ﹤0.01% |
11,108
+1,313
| +13% | +$88.5K |
|
2549
iShares Emerging Markets Equity Factor ETF
EMGF
$1.74B
| $770K | ﹤0.01% |
10,514
-208
| -2% | -$14.6K |
|
2550
VanEck Natural Resources ETF
HAP
$299M
| $770K | ﹤0.01% |
11,226
+7,021
| +167% | +$506K |
|
Similar funds
AS
LP
Cambridge Investment Research Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Cambridge Investment Research Advisors held 4,226 positions worth $44.6B, up 15% from $38.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Cambridge Investment Research Advisors's Q2 2026 filing shows 302 new, 2,051 increased, 1,607 reduced and 183 closed positions. Its largest new stake was SpaceX: 260,155 shares worth $44.5M. The largest sale was JPMorgan Ultra-Short Income ETF, an estimated $73.5M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- Cambridge Investment Research Advisors's largest Q2 2026 buy was SpaceX: 260,155 shares worth $44.5M.
- Cambridge Investment Research Advisors added most to State Street SPDR Portfolio S&P 500 ETF in Q2 2026, an estimated $126M increase.
- Cambridge Investment Research Advisors's biggest Q2 2026 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $73.5M.
- Cambridge Investment Research Advisors fully exited ProShares UltraShort S&P500 in Q2 2026, selling an estimated $3.26M.
- Cambridge Investment Research Advisors's ten largest holdings make up 19% of its $44.6B portfolio in Q2 2026.
- Cambridge Investment Research Advisors opened 302 new positions and closed 183 in Q2 2026.
- Cambridge Investment Research Advisors's portfolio value rose 15% quarter-over-quarter to $44.6B.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.